Nielsen et al. [44] found that CD20+ B cells co-localized with CD8+ T cells in high-grade serous ovarian cancer, raising the possibility that B lymphocytes may act as antigen-presenting cells to facilitate the antitumoral T cell cytolytic response. This evidence concerns the gene CD8A and ovarian serous adenocarcinoma.